Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 2
1966 5
1967 9
1968 7
1969 11
1970 15
1971 10
1972 18
1973 17
1974 14
1975 17
1976 18
1977 12
1978 18
1979 16
1980 12
1981 19
1982 15
1983 16
1984 25
1985 28
1986 26
1987 41
1988 43
1989 66
1990 88
1991 83
1992 137
1993 194
1994 220
1995 235
1996 276
1997 307
1998 330
1999 358
2000 400
2001 440
2002 402
2003 447
2004 474
2005 529
2006 594
2007 550
2008 578
2009 633
2010 686
2011 792
2012 899
2013 934
2014 1026
2015 1131
2016 1162
2017 1089
2018 1055
2019 1157
2020 1291
2021 1204
2022 1181
2023 1089
2024 314

Text availability

Article attribute

Article type

Publication date

Search Results

20,587 results

Results by year

Filters applied: . Clear all
Page 1
Treatment of epithelial ovarian cancer.
Kuroki L, Guntupalli SR. Kuroki L, et al. BMJ. 2020 Nov 9;371:m3773. doi: 10.1136/bmj.m3773. BMJ. 2020. PMID: 33168565 Review.
New therapies for clear cell ovarian carcinoma.
Stewart J, Cunningham N, Banerjee S. Stewart J, et al. Int J Gynecol Cancer. 2023 Mar 6;33(3):385-393. doi: 10.1136/ijgc-2022-003704. Int J Gynecol Cancer. 2023. PMID: 36878571 Review.
European experts consensus: BRCA/homologous recombination deficiency testing in first-line ovarian cancer.
Vergote I, González-Martín A, Ray-Coquard I, Harter P, Colombo N, Pujol P, Lorusso D, Mirza MR, Brasiuniene B, Madry R, Brenton JD, Ausems MGEM, Büttner R, Lambrechts D; European experts’ consensus group. Vergote I, et al. Ann Oncol. 2022 Mar;33(3):276-287. doi: 10.1016/j.annonc.2021.11.013. Epub 2021 Dec 1. Ann Oncol. 2022. PMID: 34861371 Free article. Review.
Tumor-reactive antibodies evolve from non-binding and autoreactive precursors.
Mazor RD, Nathan N, Gilboa A, Stoler-Barak L, Moss L, Solomonov I, Hanuna A, Divinsky Y, Shmueli MD, Hezroni H, Zaretsky I, Mor M, Golani O, Sabah G, Jakobson-Setton A, Yanichkin N, Feinmesser M, Tsoref D, Salman L, Yeoshoua E, Peretz E, Erlich I, Cohen NM, Gershoni JM, Freund N, Merbl Y, Yaari G, Eitan R, Sagi I, Shulman Z. Mazor RD, et al. Cell. 2022 Mar 31;185(7):1208-1222.e21. doi: 10.1016/j.cell.2022.02.012. Epub 2022 Mar 18. Cell. 2022. PMID: 35305314 Free article.
The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer.
Garsed DW, Pandey A, Fereday S, Kennedy CJ, Takahashi K, Alsop K, Hamilton PT, Hendley J, Chiew YE, Traficante N, Provan P, Ariyaratne D, Au-Yeung G, Bateman NW, Bowes L, Brand A, Christie EL, Cunningham JM, Friedlander M, Grout B, Harnett P, Hung J, McCauley B, McNally O, Piskorz AM, Saner FAM, Vierkant RA, Wang C, Winham SJ, Pharoah PDP, Brenton JD, Conrads TP, Maxwell GL, Ramus SJ, Pearce CL, Pike MC, Nelson BH, Goode EL, DeFazio A, Bowtell DDL. Garsed DW, et al. Nat Genet. 2022 Dec;54(12):1853-1864. doi: 10.1038/s41588-022-01230-9. Epub 2022 Dec 1. Nat Genet. 2022. PMID: 36456881 Free PMC article.
Metabolic dependencies and targets in ovarian cancer.
Zhang Y, Wang Y, Zhao G, Orsulic S, Matei D. Zhang Y, et al. Pharmacol Ther. 2023 May;245:108413. doi: 10.1016/j.pharmthera.2023.108413. Epub 2023 Apr 13. Pharmacol Ther. 2023. PMID: 37059310 Review.
20,587 results
You have reached the last available page of results. Please see the User Guide for more information.